Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Brantsæter AB[au]:

Clinical Management of Ebola Virus Disease in the United States and Europe. Uyeki TM et al. N Engl J Med. (2016)

Non-tuberculous mycobacterial pulmonary infections. Tveiten H et al. Tidsskr Nor Laegeforen. (2018)

[Tattooed norwegian tourist with fever and rashes]. Bø K et al. Tidsskr Nor Laegeforen. (2017)

Search results

Items: 30

1.

Bacille Calmette-Guérin vaccination of healthcare personnel: changing epidemiology calls for new recommendations in Norway.

Arnesen TM, Brantsæter AB, Nøkleby H.

Eur Respir J. 2019 Jan 10;53(1). pii: 1801123. doi: 10.1183/13993003.01123-2018. Print 2019 Jan. No abstract available.

PMID:
30630851
2.

Non-tuberculous mycobacterial pulmonary infections.

Tveiten H, Brantsæter AB, Mengshoel AT.

Tidsskr Nor Laegeforen. 2018 Nov 26;138(19). doi: 10.4045/tidsskr.18.0077. Print 2018 Nov 27. Review. English, Norwegian.

3.

Stratification by interferon-γ release assay level predicts risk of incident TB.

Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM.

Thorax. 2018 Apr 5. pii: thoraxjnl-2017-211147. doi: 10.1136/thoraxjnl-2017-211147. [Epub ahead of print]

PMID:
29622693
4.

Effect of Oseltamivir (Tamiflu®) for the Prevention and Treatment of Influenza During an Influenza Pandemic [Internet].

Mørland B, Brantsæter AB, Fuglesang JE, Haaheim LR, Løvoll Ø, Salmén R, Sjursen H, Kristiansen IS, Wisløff T, Ørjasæter Elvsaas IK, Nilsen E.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005.

5.

[Tattooed norwegian tourist with fever and rashes].

Bø K, Skullerud KH, Mengshoel AT, Eldholm V, Brantsæter AB.

Tidsskr Nor Laegeforen. 2017 Feb 7;137(3):205-207. doi: 10.4045/tidsskr.16.0710. eCollection 2017 Feb. Norwegian. No abstract available.

6.

Hepatitis E - a neglected disease in Norway.

Brantsæter AB.

Tidsskr Nor Laegeforen. 2016 Oct 25;136(19):1604. eCollection 2016 Oct. English, Norwegian. No abstract available.

7.

Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen.

Bates M, Brantsaeter AB.

J Virus Erad. 2016 Jul 1;2(3):136-42.

8.

Clinical Management of Ebola Virus Disease in the United States and Europe.

Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J; Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe.

N Engl J Med. 2016 Feb 18;374(7):636-46. doi: 10.1056/NEJMoa1504874.

9.

Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013.

MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BÅ, Jonsrud K, Lundgren B, Mellegård H, Møller-Stray J, Rønning K, Vestrheim DF, Vold L.

Euro Surveill. 2013 Nov 7;18(45):20630.

10.

Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania.

Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D.

Int J Infect Dis. 2012 Dec;16(12):e879-85. doi: 10.1016/j.ijid.2012.08.003. Epub 2012 Sep 30.

11.

Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries.

De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G; European Network for Highly Infectious Diseases Working Group.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1008-16. doi: 10.1086/667729. Epub 2012 Aug 27.

PMID:
22961020
12.

[Malaria treatment--herbal therapy in new clothes].

Brantsæter AB.

Tidsskr Nor Laegeforen. 2012 Mar 27;132(6):614. doi: 10.4045/tidsskr.12.0238. Norwegian. No abstract available.

13.

[Did vaccines and hygiene recommendations affect the pandemic?].

Brantsæter AB.

Tidsskr Nor Laegeforen. 2011 Apr 8;131(7):662. doi: 10.4045/tidsskr.11.0318. Norwegian. No abstract available.

14.

[An underestimated throat bacteria].

Brantsaeter AB.

Tidsskr Nor Laegeforen. 2009 Sep 10;129(17):1756. doi: 10.4045/tidsskr.09.0788. Norwegian. No abstract available.

15.

Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.

Brantsaeter AB, Romanus V, Andersen PH, Heldal E.

Int J Tuberc Lung Dis. 2009 Apr;13(4):440-5.

PMID:
19335948
16.

[Action against tuberculosis--all has its time].

Brantsaeter AB.

Tidsskr Nor Laegeforen. 2008 Dec 18;128(24):2817. Norwegian. No abstract available.

17.

Nationwide study of invasive Pseudomonas aeruginosa infection in Norway: importance of underlying disease.

Iversen BG, Brantsaeter AB, Aavitsland P.

J Infect. 2008 Aug;57(2):139-46. doi: 10.1016/j.jinf.2008.05.010. Epub 2008 Jul 9.

PMID:
18617269
18.

CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study.

Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN.

BMC Infect Dis. 2007 Nov 6;7:127.

19.

[Acute hepatitis E].

Sarvari SI, Hoddevik G, Brantsaeter AB.

Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1966-8. Norwegian. No abstract available.

20.

Tularaemia outbreak in northern Norway.

Brantsaeter AB, Krogh T, Radtke A, Nygard K.

Euro Surveill. 2007 Mar 29;12(3):E070329.2. No abstract available.

PMID:
17439796
21.

Outbreak of community-acquired legionnaires disease in southeast Norway, May 2005.

Blystad H, Brantsaeter AB, Lovoll Ø.

Euro Surveill. 2005 May 26;10(5):E050526.1. No abstract available.

PMID:
16770016
22.

[Tularemia].

Brantsaeter AB.

Tidsskr Nor Laegeforen. 2006 Apr 6;126(8):1034. Norwegian. No abstract available.

23.

Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004.

Nygård K, Brantsaeter AB, Mehl R.

Euro Surveill. 2005 Oct;10(10):235-8.

PMID:
16282646
24.

Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004.

Nygård K, Brantsaeter AB, Mehl R.

Euro Surveill. 2005 Oct;10(10):1-2. doi: 10.2807/esm.10.10.00568-en.

PMID:
29208085
25.

Treatment outcome of new culture positive pulmonary tuberculosis in Norway.

Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G.

BMC Public Health. 2005 Feb 7;5:14.

26.

CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo.

Brantsaeter AB, Liestøl K, Goplen AK, Dunlop O, Bruun JN.

Scand J Infect Dis. 2002;34(1):50-5.

PMID:
11874165
27.

[Tick-borne encephalitis in Norway].

Ormaasen V, Brantsaeter AB, Moen EW.

Tidsskr Nor Laegeforen. 2001 Mar 10;121(7):807-9. Norwegian.

28.

Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals.

Dyrhol-Riise AM, Brantsaeter AB, Dunlop O, Baklien K, Skar AG, Asjö B, Bruun JN, Røsok BI.

Scand J Immunol. 2000 Feb;51(2):195-201.

29.

[Tularemia after tick bite in Vestfold].

Brantsaeter AB, Hoel T, Kristianslund TI, Maeland A.

Tidsskr Nor Laegeforen. 1998 Mar 20;118(8):1191-3. Norwegian.

PMID:
9567695
30.

[Pseudomonas aeruginosa as a cause of urinary tract infections].

Brantsaeter AB, Natås OB.

Tidsskr Nor Laegeforen. 1994 Feb 20;114(5):572-4. Norwegian.

PMID:
8209341

Supplemental Content

Loading ...
Support Center